ARQT
Price
$22.84
Change
-$0.61 (-2.60%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
2.87B
110 days until earnings call
Intraday BUY SELL Signals
REGN
Price
$695.46
Change
+$13.74 (+2.02%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
71.65B
78 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARQT vs REGN

Header iconARQT vs REGN Comparison
Open Charts ARQT vs REGNBanner chart's image
Arcutis Biotherapeutics
Price$22.84
Change-$0.61 (-2.60%)
Volume$55.61K
Capitalization2.87B
Regeneron Pharmaceuticals
Price$695.46
Change+$13.74 (+2.02%)
Volume$18.88K
Capitalization71.65B
ARQT vs REGN Comparison Chart in %
ARQT
Daily Signal:
Gain/Loss:
REGN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ARQT vs. REGN commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARQT is a StrongBuy and REGN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (ARQT: $23.45 vs. REGN: $681.72)
Brand notoriety: ARQT: Not notable vs. REGN: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARQT: 71% vs. REGN: 113%
Market capitalization -- ARQT: $2.87B vs. REGN: $71.65B
ARQT [@Biotechnology] is valued at $2.87B. REGN’s [@Biotechnology] market capitalization is $71.65B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARQT’s FA Score shows that 0 FA rating(s) are green whileREGN’s FA Score has 1 green FA rating(s).

  • ARQT’s FA Score: 0 green, 5 red.
  • REGN’s FA Score: 1 green, 4 red.
According to our system of comparison, REGN is a better buy in the long-term than ARQT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARQT’s TA Score shows that 3 TA indicator(s) are bullish while REGN’s TA Score has 6 bullish TA indicator(s).

  • ARQT’s TA Score: 3 bullish, 5 bearish.
  • REGN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, REGN is a better buy in the short-term than ARQT.

Price Growth

ARQT (@Biotechnology) experienced а -3.81% price change this week, while REGN (@Biotechnology) price change was +5.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

ARQT is expected to report earnings on Mar 03, 2026.

REGN is expected to report earnings on Jan 30, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REGN($71.6B) has a higher market cap than ARQT($2.87B). ARQT YTD gains are higher at: 68.342 vs. REGN (-3.887). REGN has higher annual earnings (EBITDA): 5.42B vs. ARQT (-68.35M). REGN has more cash in the bank: 7.47B vs. ARQT (191M). ARQT has less debt than REGN: ARQT (110M) vs REGN (2.71B). REGN has higher revenues than ARQT: REGN (14.2B) vs ARQT (263M).
ARQTREGNARQT / REGN
Capitalization2.87B71.6B4%
EBITDA-68.35M5.42B-1%
Gain YTD68.342-3.887-1,758%
P/E RatioN/A16.34-
Revenue263M14.2B2%
Total Cash191M7.47B3%
Total Debt110M2.71B4%
FUNDAMENTALS RATINGS
REGN: Fundamental Ratings
REGN
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
88
SMR RATING
1..100
54
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
67
SEASONALITY SCORE
1..100
44

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARQTREGN
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
44%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
54%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 2 days ago
63%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 10 days ago
52%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
43%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
ARQT
Daily Signal:
Gain/Loss:
REGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SCJ92.110.39
+0.42%
iShares MSCI Japan Small-Cap ETF
RSPA51.160.16
+0.31%
Invesco S&P 500 Eq Wght Inc Adv ETF
KORP47.56-0.01
-0.02%
American Century Dvrs Corp Bd ETF
VCLT77.18-0.15
-0.19%
Vanguard Long-Term Corporate Bd ETF
PXJ29.68-0.74
-2.43%
Invesco Oil & Gas Services ETF

ARQT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARQT has been loosely correlated with IDYA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ARQT jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARQT
1D Price
Change %
ARQT100%
-2.41%
IDYA - ARQT
45%
Loosely correlated
-0.19%
NUVL - ARQT
44%
Loosely correlated
+0.91%
WVE - ARQT
44%
Loosely correlated
-4.20%
NRIX - ARQT
43%
Loosely correlated
-5.37%
VRDN - ARQT
43%
Loosely correlated
+1.79%
More

REGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, REGN has been loosely correlated with BMRN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if REGN jumps, then BMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REGN
1D Price
Change %
REGN100%
+1.06%
BMRN - REGN
44%
Loosely correlated
+0.71%
SMMT - REGN
40%
Loosely correlated
-1.72%
ARQT - REGN
38%
Loosely correlated
-2.41%
ROIV - REGN
37%
Loosely correlated
+2.01%
INCY - REGN
37%
Loosely correlated
+0.09%
More